Cancer Weekly
Susan Hasty, Publisher
Table of Contents . . . September 4th, 2001
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Cancer Weekly | Other Publications
Breast Cancer - Micro- and Macrometastatic Growth Patterns Differ In Human Tumors
Non-Hodgkin Lymphoma - Gemcitabine Effective But Toxic For Relapsed Patients
AIDS-Related Non-Hodgkin Lymphoma - Antiretroviral Treatment Response Improves Chemotherapy Response
Breast Cancer - Cell-Surface Molecule May Hold Key To Prevention
Hematological Cancer - Elderly Patients Can Benefit From Stem Cell Autotransplants
Leukemia - Enzyme Deficiency Linked To Childhood Leukemia
Pancreatic Cancer - Growth Factor Inhibitor - Gemcitabine Combination Blocks Tumor Growth
Prostate Cancer - VEGF Levels Signify Disease In Patients With Hormone Refractory Malignancy
Brain Cancer - Intraoperative Radiation System Offers New Hope To Pediatric Patients
Breast Cancer - Group Supports Prophylactic Mastectomy Option For High-Risk Women
Breast Cancer - Weekly Docetaxel Is Promising For Older Patients
Chronic Lymphocytic Leukemia - High Tumor CD38 Expression Linked To Poor Prognosis
Chronic Myeloid Leukemia - Chemotherapy Regimen Affects Ph-Negative Stem Cell Yields
Colon Cancer - Gene Therapy Complements Chemotherapy
Diagnostics - Noninvasive, Early Detection Procedure May Aid Early Finding Of Cancer
Epstein-Barr Virus - PCR Measurements Can Determine Treatment After Stem Cell Grafts
Glioma - Caspase-9 Expression Can Override Resistance To p53-Mediated Apoptosis
Hepatocellular Carcinoma - CD40L Gene Therapy Eradicated Tumors In Rats
Lymphoma - Fas Mutations Linked To Heightened Risk
Melanoma - Ganglioside Vaccine Induces Tumor Protection In B16 Mouse Model
Melanoma - Genetic Mutation May Be Key To Onset Of Deadly Skin Cancer
Multiple Myeloma - Combination Therapy Overcomes Drug Resistance
Non-Hodgkin Lymphoma - Cerebrospinal Fluid CD23 Levels Can Mark AIDS-Related Disease
Prostate Cancer - Telomerase Inhibition Reduces Cell Viability
Stomach Cancer - Sprayable Hydrogel Mixed With Patient's Plasma Stops Bleeding
Urology - Five-Year, $6.9 Million Study Looks At Impact Of Urologic Disease On Americans
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
